Standardisation and international adoption of defined approaches for skin sensitisation

In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable fo...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in toxicology 2022-08, Vol.4, p.943152-943152
Main Authors: Casati, Silvia, Asturiol, David, Browne, Patience, Kleinstreuer, Nicole, Régimbald-Krnel, Michèle, Therriault, Pierre
Format: Article
Language:English
Subjects:
adverse outcome pathway
defined approaches
international harmonisation
mechanistic relevance
non-animal alternative methods
Toxicology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable for hazard identification and potency sub-categorisation. A number of defined approaches (DAs), using fixed data interpretation procedures (DIP) to integrate data from multiple non-animal information sources, were proposed and documented using a standard reporting template developed by the Organisation for Economic Co-operation and Development (OECD). Subsequent international activities focused on the extensive characterisation of three of these DAs with respect to the reference in vivo data, applicability domains, limitations, predictive performances and characterisations of the level of confidence associated with the predictions. The ultimate product of this project was an OECD Guideline that provides information equivalent to that provided by the animal studies and that can be used to satisfy countries’ regulatory data requirements for skin sensitisation. This Defined Approach Guideline was the first of its kind for the OECD, and provides an important precedent for regulatory adoption of human biology-relevant new approach methodologies with performances equivalent to, or better than, traditional animal tests. This mini review summarizes the principal features of the defined approaches described in OECD guideline 497.
ISSN:2673-3080
2673-3080
DOI:10.3389/ftox.2022.943152